The use of laser interstitial thermal therapy in the treatment of brain metastases: a literature review.


Journal

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
ISSN: 1464-5157
Titre abrégé: Int J Hyperthermia
Pays: England
ID NLM: 8508395

Informations de publication

Date de publication:
07 2020
Historique:
entrez: 17 7 2020
pubmed: 17 7 2020
medline: 27 5 2021
Statut: ppublish

Résumé

The aim of this paper is to discuss the current evidence for Laser Interstitial Thermal Therapy (LITT) in the treatment of brain metastases, our current recommendations for patient selection and the future perspectives for this therapy. We have also touched upon the possible complications and role of systemic therapy coupled with LITT for the treatment of brain metastases. Two authors carried out the literature search using two databases independently, including PubMed, and Web of Science. The review included prospective and retrospective studies using LITT to treat brain metastases. Twenty-two original articles were analyzed in this review, particularly clinical outcomes and complications. We have also provided our institutional experience in the use of LITT to treat brain metastases and addressed future perspectives for the use of this technology. The current literature supports LITT as a safe and effective therapy for patients with brain metastases that have failed SRS. Larger studies are still required to better evaluate the use of systemic therapy in concomitance with LITT. New images modalities may enable optimized treatment and outcomes.

Identifiants

pubmed: 32672122
doi: 10.1080/02656736.2020.1748238
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

53-60

Auteurs

Dhiego Chaves de Almeida Bastos (DCA)

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

David T Fuentes (DT)

Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Jeffrey Traylor (J)

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Jeffrey Weinberg (J)

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Vinodh A Kumar (VA)

Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Jason Stafford (J)

Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Jing Li (J)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Ganesh Rao (G)

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Sujit S Prabhu (SS)

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH